Capital allocation, M&A due diligence, portfolio construction, ROI underwriting.
Your PE sponsor puts a competitor on your desk: $4M asking price, $1.2M Revenue, $300K EBITDA. The CFO needs your recommendation in 30 days - deploy the capital or pass. You know the operations better than anyone on the deal team. Now you have to build the case that real money rides on.
Underwriting is the disciplined process of combining Valuation, Expected Return, and Risk Tolerance into a deploy-or-pass recommendation on a Capital Investment. The model matters less than the assumptions behind it - your job is to make those assumptions explicit, testable, and honest.
Underwriting is the process of building and defending the case for deploying capital into a specific opportunity. It is not a single calculation - it is a structured argument.
You already know the pieces. Valuation tells you what the Asset is worth to you specifically. Expected Return gives you the probability-weighted outcome across scenarios. Risk Tolerance tells you whether you can absorb the downside without being forced into bad decisions.
Underwriting is the discipline of combining all three into a single recommendation: deploy or pass. The output is typically a model (spreadsheet) and a memo (narrative) that makes your assumptions explicit enough for someone else to challenge them.
The word comes from insurance - literally signing your name under the risk you are accepting. In an operating context, you are signing your name under the assumptions that justify the investment.
Every material Capital Investment you make as an Operator goes through some form of underwriting - whether you call it that or not.
The Operator who can underwrite well gets two things: the ability to secure capital from the people who control it (the CFO, the Allocator, the board), and the discipline to kill bad investments before they consume resources.
Bad underwriting is how companies end up with $2M projects that return nothing. Good underwriting is how you get the $2M approved for the project that returns $8M.
Underwriting follows a repeatable structure:
What are you investing in? What is the total capital required (Implementation Cost plus ongoing costs)? What is the Time Horizon?
Model the expected Cash Flow over the Investment Horizon. This means projecting Revenue, Cost Structure, and the resulting Profit year by year. Use real numbers from the business, not industry averages.
Every model depends on assumptions. The critical ones for most underwriting:
For each key assumption, run a Sensitivity Analysis. Change one variable at a time and watch what happens to Returns. This tells you which assumptions actually matter.
What happens if your two most sensitive assumptions both go wrong? This is not pessimism - it is the scenario you test against your Risk Tolerance. If the downside wipes out your Emergency Fund or forces bad decisions elsewhere, the Expected Return does not matter.
For the base case and the downside case, compute:
Compare these against your Hurdle Rate - the minimum return you require for this level of risk.
Deploy, pass, or modify. A good underwriting memo states the recommendation up front, then walks through the logic so anyone can challenge it.
Formal underwriting (full model, written memo, Sensitivity Analysis):
Lightweight underwriting (back-of-envelope, verbal defense):
Skip it when:
You operate a $10M Revenue SaaS business (PE-Backed). A competitor with $1.2M ARR and $300K EBITDA is available for $4M. Your Hurdle Rate is 20% IRR. Integration will cost $200K and take 6 months. You expect 10% customer Churn from the transition and $150K in annual Cost Reduction from consolidating overhead.
Total capital required: $4M purchase price + $200K Implementation Cost = $4.2M deployed.
Base case Revenue: $1.2M ARR minus 10% Churn = $1.08M Year 1. Assume 5% growth thereafter: $1.13M Year 2, $1.19M Year 3, $1.25M Year 4, $1.31M Year 5.
Base case EBITDA: $300K current minus Churn impact (~$30K) plus $150K Cost Reduction = $420K Year 1. Growing with Revenue: ~$440K Year 2, ~$462K Year 3, ~$485K Year 4, ~$509K Year 5.
Base case NPV at 20% Discount Rate: Sum of discounted EBITDA over 5 years = $420K/1.20 + $440K/1.44 + $462K/1.73 + $485K/2.07 + $509K/2.49 = $350K + $306K + $267K + $234K + $204K = $1.36M. This is well below the $4.2M investment - the deal does not work on Cash Flow alone.
You need an exit assumption: If the acquired portion reaches ~$509K EBITDA and you exit at an Enterprise Value equal to 10 times EBITDA, that is ~$5.1M. Discounted at 20% over 5 years: $5.1M / 2.49 = $2.05M. Total NPV = $1.36M + $2.05M = $3.41M vs $4.2M deployed. NPV is negative by $790K. The base case fails the Hurdle Rate.
Sensitivity Analysis: The deal only works if (a) Churn drops to 0% AND Revenue growth is 10%+, or (b) the exit Enterprise Value exceeds 14 times EBITDA. Both require assumptions you cannot defend with evidence from the business.
Recommendation: Pass. The Valuation is too high for the Cash Flow. Counter-offer at $2.8M if the strategic value (Market Share, customer overlap) justifies re-underwriting at a lower price.
Insight: Good underwriting kills more deals than it approves. The discipline is in the pass - not the deploy. Notice the deal felt reasonable ($4M for $1.2M Revenue) but the math did not support it at a 20% Hurdle Rate. The Valuation looked cheap on Revenue but expensive on discounted Cash Flow.
Your operations team processes 100,000 units per year at a Cost Per Unit of $12. A $500K platform rebuild promises to cut Cost Per Unit to $7.20 (40% Cost Reduction). The build takes 8 months. Your Hurdle Rate is 15% IRR.
Annual savings: 100,000 units x ($12.00 - $7.20) = $480K per year in Cost Reduction.
Payback Period: $500K / $480K = 1.04 years from completion, or about 1.7 years from project start (including the 8-month build). Well under a typical 3-year threshold.
IRR over 3 years post-completion: Deploy $500K at project start, receive $0 for months 1-8, then $480K per year for 3 years. IRR is approximately 71%. Clears the 15% Hurdle Rate by a wide margin.
Sensitivity Analysis - volume risk: If volume drops 30% to 70,000 units, annual savings fall to $336K. Payback Period extends to 1.49 years from completion. IRR over 3 years drops to ~42%. Still clears the hurdle comfortably.
Sensitivity Analysis - cost reduction risk: If the platform only achieves 20% Cost Reduction instead of 40%, savings = $240K per year. Payback Period = 2.08 years. IRR drops to ~18%. Barely clears the Hurdle Rate - this is your risk boundary.
Recommendation: Deploy. The base case IRR provides substantial buffer above the Hurdle Rate. Even if the Cost Reduction is half of what the team promises, you still clear 15%. The key assumption to track post-deploy: actual Cost Per Unit after migration.
Insight: ROI underwriting on Operating Investments is simpler than M&A because you control more variables. The cost savings are measurable and the assumptions are testable against your own data. When the Sensitivity Analysis shows you clear the Hurdle Rate even in the downside case, that is a strong underwriting.
Underwriting is assumption management - the model is only as good as the assumptions you feed it, and your job is to make those assumptions explicit and challengeable.
Good underwriting kills more deals than it approves. The discipline is in saying 'pass' when the math does not work, regardless of how attractive the opportunity feels.
Always run Sensitivity Analysis on your top 2-3 assumptions. If the deal only works when everything goes right, you do not have a base case - you have a best case dressed up as one.
Underwriting to a conclusion: Starting with 'yes' and building the model to justify it. This is the most common failure mode in both M&A due diligence and ROI underwriting. If your CFO asks 'what assumptions would have to be true for this to work?' and you cannot list them instantly, you underwrote backwards. The model should surface the answer, not confirm it.
Ignoring the exit or terminal assumption: Many underwriting models look terrible on Cash Flow alone and only work when you assume a favorable exit Valuation. If your entire return depends on selling the Asset at a high ratio of Enterprise Value to EBITDA, you have moved your risk from Operations (which you control) to market conditions (which you do not). Always know what percentage of your NPV comes from the exit assumption - if it is more than 50%, your underwriting is fragile.
You are considering a $200K investment in a new tool that will generate $80K per year in additional Cash Flow for 4 years. Your Hurdle Rate is 15%. Compute the NPV and make a deploy-or-pass recommendation.
Hint: Discount each year's $80K Cash Flow at 15%. Year 1 divisor is 1.15, Year 2 is 1.15 squared (1.32), and so on. Sum the discounted values and subtract the $200K investment.
Discounted Cash Flow: $80K/1.15 + $80K/1.32 + $80K/1.52 + $80K/1.75 = $69.6K + $60.6K + $52.6K + $45.7K = $228.5K. NPV = $228.5K - $200K = +$28.5K. The NPV is positive, so the investment clears the 15% Hurdle Rate. Deploy. The IRR is approximately 22%, giving you a 7-point buffer above the hurdle.
A 3-location services business does $2.4M Revenue with $360K EBITDA. The asking price is $2.5M. Your Hurdle Rate is 18% IRR. You expect $50K in integration costs and 5% Revenue Churn in Year 1. Build the underwriting: deploy or pass? Assume 3% Revenue growth after Year 1, a 5-year hold, and an exit Enterprise Value of 8 times Year 5 EBITDA.
Hint: Start with Year 1 adjusted Revenue ($2.4M x 0.95). Compute EBITDA as the same percentage of Revenue (15%), then grow Revenue at 3% for Years 2-5 and hold the EBITDA percentage constant. Discount everything at 18%. Do not forget to add the exit value in Year 5.
Year 1 Revenue: $2.28M. EBITDA percentage of Revenue is $360K/$2.4M = 15%, so Year 1 EBITDA = $342K. Years 2-5 at 3% Revenue growth: EBITDA of $352K, $363K, $374K, $385K. Total capital deployed: $2.55M ($2.5M + $50K). NPV of EBITDA at 18%: $342K/1.18 + $352K/1.39 + $363K/1.64 + $374K/1.94 + $385K/2.29 = $290K + $253K + $221K + $193K + $168K = $1.13M. Exit Enterprise Value in Year 5: $385K x 8 = $3.08M, discounted at 18% = $3.08M/2.29 = $1.34M. Total NPV = $1.13M + $1.34M = $2.47M vs $2.55M deployed. NPV is slightly negative (-$80K). The deal barely misses at 18%. Recommendation: counter-offer at $2.3M or identify $30K+ in annual Cost Reduction from integration to make the math work.
You have $1M in Capital Allocation budget this year. Three underwritten opportunities: (A) Platform rebuild - $500K, IRR 45%, Payback Period 1.5 years. (B) Acquisition - $800K, IRR 22%, Payback Period 3.2 years. (C) Sales team expansion - $300K, IRR 35%, Payback Period 1.1 years. You cannot fund all three. Which do you fund and why?
Hint: Total cost of all three is $1.6M, which exceeds your $1M Budget. List the feasible combinations and compare them on total capital deployed, combined return profile, and Payback Period. Consider what Payback Period tells you about risk that IRR does not.
Feasible combinations within $1M: (A+C) = $800K deployed, (B alone) = $800K, (A alone) = $500K, (C alone) = $300K. A+C deploys $800K with a weighted IRR around 41% and both Payback Periods under 1.5 years. B alone deploys $800K at 22% IRR with a 3.2-year Payback Period. A+C dominates B on both return and speed of capital recovery - faster Payback Period means lower Execution Risk and earlier reinvestment. Fund A and C ($800K). Hold the remaining $200K as Liquidity for opportunities that emerge mid-year. Key insight: Portfolio Construction is not just picking the highest IRR in isolation - it is maximizing return across your full Capital Allocation while respecting the Budget constraint and managing risk through Payback Period.
Underwriting sits at the convergence of the three prerequisites you have already learned. Risk Tolerance sets the boundary - it tells you the maximum downside you can absorb, which directly constrains which deals survive the underwriting process. Expected Return is the core calculation inside the underwriting model - you are computing the probability-weighted outcome across your base case and downside scenarios. Valuation provides the anchor - what the Asset is worth to you specifically, given your Cost Structure and Revenue assumptions. Without all three, you are guessing.
Underwriting connects forward to Capital Allocation (deciding how to distribute capital across multiple underwritten opportunities), Portfolio Construction (how your collection of underwritten investments combines into an overall risk-return profile), and the intensive variant of M&A due diligence (underwriting applied specifically to acquisitions, where the assumptions are harder to verify and the stakes are higher). It also depends heavily on Sensitivity Analysis as the core technique for stress-testing assumptions, and Hurdle Rate as the threshold every underwriting must clear before capital moves.
Disclaimer: This content is for educational and informational purposes only and does not constitute financial, investment, tax, or legal advice. It is not a recommendation to buy, sell, or hold any security or financial product. You should consult a qualified financial advisor, tax professional, or attorney before making financial decisions. Past performance is not indicative of future results. The author is not a registered investment advisor, broker-dealer, or financial planner.